gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma.

Schwartzentruber, D. J., Lawson, D. H., Richards, J. M., Conry, R. M., Miller, D. M., Treisman, J., Gailani, F., Riley, L., Conlon, K., Pockaj, B., Kendra, K. L., Whit...; N Engl J Med. 2011 Jun 2.

Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer.

Zweifel, M., Jayson, G. C., Reed, N. S., Osborne, R., Hassan, B., Ledermann, J., Shreeves, G., Poupard, L., Lu, S. P., Balkissoon, J., Chaplin, D. J., Rustin, G. J.; Ann Oncol. 2011 Sep.

A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer.

Rustin, G. J., Shreeves, G., Nathan, P. D., Gaya, A., Ganesan, T. S., Wang, D., Boxall, J., Poupard, L., Chaplin, D. J., Stratford, M. R., Balkissoon, J., Zweifel, M.; Br J Cancer. 2010 Apr 27.